Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,673 GBX | +0.18% | +2.04% | +15.36% |
04-30 | First trial over Zantac cancer claims set to begin in Chicago | RE |
04-30 | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.36% | 85.64B | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GlaxoSmithKline : iTeos Signs Cancer Drug Development Deal That Could Potentially Bring $2 Billion